Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP208261.RAAHLsCAI4AN796F04Z2thXwyhR0MhY9lSrf9-okLiZBE130_assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208261.RAAHLsCAI4AN796F04Z2thXwyhR0MhY9lSrf9-okLiZBE130_provenance.
• NP290329.RATV8jZWtj3NhVSAW53SMnn_ORTgCzyaL0IIwSEd3Ai6o130_assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290329.RATV8jZWtj3NhVSAW53SMnn_ORTgCzyaL0IIwSEd3Ai6o130_provenance.
• NP904377.RATR-1WPvW7TtiZYp_hc9tFD0G-H9XdGtkjOnx2nFRjKo130_assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904377.RATR-1WPvW7TtiZYp_hc9tFD0G-H9XdGtkjOnx2nFRjKo130_provenance.
• NP593110.RAzOxVXifG9ffgxjTgu2vs7UPQ5WyWduUscGDaCPkIxwE130_assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593110.RAzOxVXifG9ffgxjTgu2vs7UPQ5WyWduUscGDaCPkIxwE130_provenance.
• NP823819.RAt9PZRdp9lHYgryP9nqJaes6rQv9i80z6E0XRgWwIW2I130_assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823819.RAt9PZRdp9lHYgryP9nqJaes6rQv9i80z6E0XRgWwIW2I130_provenance.
• assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP954863.RAVkELPHvndqtwVcaD5hMJkN01uKPKx-HwDtyzZG0HYHU130_assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954863.RAVkELPHvndqtwVcaD5hMJkN01uKPKx-HwDtyzZG0HYHU130_provenance.
• NP636124.RACG85P_uALZv5IAKPWAUyI1bUsCjLTuyTcE_0lZ2vboo130_assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636124.RACG85P_uALZv5IAKPWAUyI1bUsCjLTuyTcE_0lZ2vboo130_provenance.
• NP820105.RACxF2JieyeFa9Q0Fk8YJCJ96-KjzMCR53m6HE2IEsPY4130_assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820105.RACxF2JieyeFa9Q0Fk8YJCJ96-KjzMCR53m6HE2IEsPY4130_provenance.
• NP708284.RAuEZEAG1Jrn7fs86Fg80jXwm-yUFWkFuzEvn03U722os130_assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708284.RAuEZEAG1Jrn7fs86Fg80jXwm-yUFWkFuzEvn03U722os130_provenance.
• NP954861.RAqE8GhccUhkw6HUVdtryWXKyWvyGi5beAzsA_1uzhlw0130_assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954861.RAqE8GhccUhkw6HUVdtryWXKyWvyGi5beAzsA_1uzhlw0130_provenance.
• NP582062.RAxGwiBbV1xDuIk4yAGDWOAXoWGNjYnrQEpWZlp_Lares130_assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582062.RAxGwiBbV1xDuIk4yAGDWOAXoWGNjYnrQEpWZlp_Lares130_provenance.
• NP954862.RA0h0AhNtSnTETad4NjjLSEE6Pv-izsVRdUZ6MC_V72lA130_assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954862.RA0h0AhNtSnTETad4NjjLSEE6Pv-izsVRdUZ6MC_V72lA130_provenance.
• NP954864.RA5TDPHKPh8tLrK-bxiTHN3sjbNc5GaweI_2JaYST4-XQ130_assertion description "[Here, we report for the first time that human dermal fibroblasts from a patient with relapsing-remitting Multiple Sclerosis (MS) were reprogrammed to pluripotency by retroviral transduction using defined factors (OCT4, SOX2, KLF4, and c-MYC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954864.RA5TDPHKPh8tLrK-bxiTHN3sjbNc5GaweI_2JaYST4-XQ130_provenance.